Choreo, LLC Ligand Pharmaceuticals Inc Transaction History
Choreo, LLC
- $7.73 Billion
- Q3 2025
A detailed history of Choreo, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Choreo, LLC holds 1,618 shares of LGND stock, worth $325,654. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,618Holding current value
$325,654% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
315Shares Held
20.2MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$578 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$418 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$213 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3752KShares$151 Million0.16% of portfolio
-
State Street Corp Boston, MA749KShares$151 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.4B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...